U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock
73.52 USD
-0.33 (-0.45%)
73.52 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to USPH. USPH was compared to 101 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. USPH is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
In the past year USPH had a positive cash flow from operations.
In the past 5 years USPH has always been profitable.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
USPH's Return On Assets of 3.01% is fine compared to the rest of the industry. USPH outperforms 65.35% of its industry peers.
The Return On Equity of USPH (7.15%) is better than 68.32% of its industry peers.
USPH has a better Return On Invested Capital (6.11%) than 63.37% of its industry peers.
USPH had an Average Return On Invested Capital over the past 3 years of 5.78%. This is below the industry average of 9.22%.
The 3 year average ROIC (5.78%) for USPH is below the current ROIC(6.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROIC | 6.11% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
With a decent Profit Margin value of 4.75%, USPH is doing good in the industry, outperforming 78.22% of the companies in the same industry.
In the last couple of years the Profit Margin of USPH has declined.
USPH has a better Operating Margin (11.52%) than 80.20% of its industry peers.
In the last couple of years the Operating Margin of USPH has declined.
Looking at the Gross Margin, with a value of 18.80%, USPH is doing worse than 63.37% of the companies in the same industry.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USPH is destroying value.
USPH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for USPH has been increased compared to 5 years ago.
USPH has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.15 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score (2.15) which is comparable to the rest of the industry.
USPH has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as USPH would need 2.82 years to pay back of all of its debts.
The Debt to FCF ratio of USPH (2.82) is better than 77.23% of its industry peers.
USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
USPH has a Debt to Equity ratio of 0.30. This is in the better half of the industry: USPH outperforms 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.72
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
The Current ratio of USPH (1.20) is comparable to the rest of the industry.
A Quick Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.20, USPH perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.17% over the past year.
The Earnings Per Share has been decreasing by -1.76% on average over the past years.
Looking at the last year, USPH shows a quite strong growth in Revenue. The Revenue has grown by 17.50% in the last year.
USPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
3.2 Future
USPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.98% yearly.
USPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.97% yearly.
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 28.28, USPH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of USPH is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.11. USPH is around the same levels.
The Price/Forward Earnings ratio is 23.57, which indicates a rather expensive current valuation of USPH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USPH is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, USPH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.28 | ||
| Fwd PE | 23.57 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, USPH is valued a bit cheaper than the industry average as 68.32% of the companies are valued more expensively.
66.34% of the companies in the same industry are more expensive than USPH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.64 | ||
| EV/EBITDA | 11.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
USPH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.01
PEG (5Y)N/A
EPS Next 2Y9.96%
EPS Next 3Y9.98%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.43%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.47. USPH pays more dividend than 94.06% of the companies in the same industry.
USPH's Dividend Yield is comparable with the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.43% |
5.2 History
On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 75.41% of its income as dividend. This is not a sustainable payout ratio.
USPH's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP75.41%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
73.52
-0.33 (-0.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.82%
Inst Owner Change5.17%
Ins Owners1.84%
Ins Owner Change-1.14%
Market Cap1.12B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target108.32 (47.33%)
Short Float %5.28%
Short Ratio4.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.43% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.88%
EPS NQ rev (3m)-3.88%
EPS NY rev (1m)0%
EPS NY rev (3m)5.2%
Revenue NQ rev (1m)1.41%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.28 | ||
| Fwd PE | 23.57 | ||
| P/S | 1.47 | ||
| P/FCF | 19.64 | ||
| P/OCF | 16.07 | ||
| P/B | 2.22 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.29 |
EPS(TTM)2.6
EY3.54%
EPS(NY)3.12
Fwd EY4.24%
FCF(TTM)3.74
FCFY5.09%
OCF(TTM)4.57
OCFY6.22%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)3.01
PEG (5Y)N/A
Graham Number44.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROCE | 8.08% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.29% | ||
| ROICexgc | 36.03% | ||
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% | ||
| FCFM | 7.5% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 1.37 | ||
| Cap/Depr | 53.9% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | 9.84 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 157.98% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 2.15 |
F-Score6
WACC8.49%
ROIC/WACC0.72
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.12%
EBIT Next 3Y18.72%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?
ChartMill assigns a fundamental rating of 5 / 10 to USPH.
Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?
ChartMill assigns a valuation rating of 4 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Fairly Valued.
What is the profitability of USPH stock?
U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for USPH stock?
The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 9.38% in the next year.
Can you provide the dividend sustainability for USPH stock?
The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.